RxDoctor Payments Data

Alexandra Jones, NP

Family · Delray Beach, FLNPI 1023651064

Payments from drug & device makers

$1,148in general payments, 2019–2025

Across 70 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$274
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$143
  • Astellas Pharma US Inc$132
  • Esperion Therapeutics, Inc.$91
  • AstraZeneca$79
  • Novartis$58
  • plus $371 from 14 others

What the payments were for

  • Food & beverage$1,01688%
  • Education$13212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,148 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$104,717
Medicare patients
434
Services billed
1,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$35,320
JardianceEmpagliflozin13$20,659
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$19,860
MyrbetriqMirabegron33$19,705
XareltoRivaroxaban18$19,278
Repatha SureclickEvolocumab21$12,766
Rosuvastatin Calcium184$1,934
Atorvastatin Calcium184$1,571
Amlodipine Besylate271$1,397
Levothyroxine Sodium161$1,328
Omeprazole66$1,171
Verapamil ErVerapamil Hcl13$1,015
Albuterol Sulfate HfaAlbuterol Sulfate33$1,005
Losartan Potassium132$976
Valsartan25$894

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$35,32027 claims
Boehringer IngelheimJardiance$49$20,65913 claims
Astellas Pharma US IncMyrbetriq$132$19,70533 claims
Johnson & JohnsonXarelto$274$19,27818 claims
AbbVieSynthroid$14$41813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 14,618 family providers in Florida.

Other family in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →